397 related articles for article (PubMed ID: 29126708)
1. Incomplete excision of cervical precancer as a predictor of treatment failure: a systematic review and meta-analysis.
Arbyn M; Redman CWE; Verdoodt F; Kyrgiou M; Tzafetas M; Ghaem-Maghami S; Petry KU; Leeson S; Bergeron C; Nieminen P; Gondry J; Reich O; Moss EL
Lancet Oncol; 2017 Dec; 18(12):1665-1679. PubMed ID: 29126708
[TBL] [Abstract][Full Text] [Related]
2. Incomplete excision of cervical intraepithelial neoplasia as a predictor of the risk of recurrent disease-a 16-year follow-up study.
Alder S; Megyessi D; Sundström K; Östensson E; Mints M; Belkić K; Arbyn M; Andersson S
Am J Obstet Gynecol; 2020 Feb; 222(2):172.e1-172.e12. PubMed ID: 31473226
[TBL] [Abstract][Full Text] [Related]
3. Prediction of recurrence after treatment for high-grade cervical intraepithelial neoplasia: the role of human papillomavirus testing and age at conisation.
Verguts J; Bronselaer B; Donders G; Arbyn M; Van Eldere J; Drijkoningen M; Poppe W
BJOG; 2006 Nov; 113(11):1303-7. PubMed ID: 16978225
[TBL] [Abstract][Full Text] [Related]
4. Long-term predictors of residual or recurrent cervical intraepithelial neoplasia 2-3 after treatment with a large loop excision of the transformation zone: a retrospective study.
Fernández-Montolí ME; Tous S; Medina G; Castellarnau M; García-Tejedor A; de Sanjosé S
BJOG; 2020 Feb; 127(3):377-387. PubMed ID: 31631477
[TBL] [Abstract][Full Text] [Related]
5. Analysis of Residual/Recurrent Disease and Its Risk Factors after Loop Electrosurgical Excision Procedure for High-Grade Cervical Intraepithelial Neoplasia.
Wu J; Jia Y; Luo M; Duan Z
Gynecol Obstet Invest; 2016; 81(4):296-301. PubMed ID: 26337009
[TBL] [Abstract][Full Text] [Related]
6. Follow-up strategies after treatment (large loop excision of the transformation zone (LLETZ)) for cervical intraepithelial neoplasia (CIN): Impact of human papillomavirus (HPV) test.
van der Heijden E; Lopes AD; Bryant A; Bekkers R; Galaal K
Cochrane Database Syst Rev; 2015 Jan; 1(1):CD010757. PubMed ID: 25562623
[TBL] [Abstract][Full Text] [Related]
7. Incomplete excision of cervical intraepithelial neoplasia and risk of treatment failure: a meta-analysis.
Ghaem-Maghami S; Sagi S; Majeed G; Soutter WP
Lancet Oncol; 2007 Nov; 8(11):985-93. PubMed ID: 17928267
[TBL] [Abstract][Full Text] [Related]
8. Optimising follow-up strategy based on cytology and human papillomavirus after fertility-sparing surgery for early stage cervical cancer: a nationwide, population-based, retrospective cohort study.
Schuurman TN; Schaafsma M; To KH; Verhoef VMJ; Sikorska K; Siebers AG; Wenzel HHB; Bleeker MCG; Roes EM; Zweemer RP; de Vos van Steenwijk PJ; Yigit R; Beltman JJ; Zusterzeel PLM; Lok CAR; Bekkers RLM; Mom CH; van Trommel NE
Lancet Oncol; 2023 Dec; 24(12):1349-1358. PubMed ID: 37952541
[TBL] [Abstract][Full Text] [Related]
9. HPV Test as Test of Cure After Conization for CIN2+: A Nationwide Register-Based Cohort Study.
Bruhn LV; Hyldig N; Schledermann D
J Low Genit Tract Dis; 2022 Oct; 26(4):287-292. PubMed ID: 36126201
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative post-conisation human papillomavirus testing for early detection of treatment failure in patients with cervical intraepithelial neoplasia: a pilot study.
Torné A; Fusté P; Rodríguez-Carunchio L; Alonso I; del Pino M; Nonell R; Cardona M; Rodríguez A; Castillo P; Pahisa J; Balasch J; Ramírez J; Ordi J
BJOG; 2013 Mar; 120(4):392-9. PubMed ID: 23189989
[TBL] [Abstract][Full Text] [Related]
11. Prediction of residual/recurrent disease by HPV genotype after loop excision procedure for high-grade cervical intraepithelial neoplasia with negative margins.
Wu D; Zheng Y; Chen W; Guo C; Yu J; Chen G; Huang Y
Aust N Z J Obstet Gynaecol; 2011 Apr; 51(2):114-8. PubMed ID: 21466511
[TBL] [Abstract][Full Text] [Related]
12. Endocervical crypt involvement by high-grade cervical intraepithelial neoplasia and its association with high-grade histopathological recurrence after cervical excision in women with negative excision margins: a systematic review and meta-analysis.
Papoutsis D; Underwood M; Parry-Smith W; Tzavara C
Arch Gynecol Obstet; 2024 Mar; 309(3):939-948. PubMed ID: 37821642
[TBL] [Abstract][Full Text] [Related]
13. Cervical cytology and HPV test in follow-up after conisation or LLETZ.
Ostojić DV; Vrdoljak-Mozetic D; Stemberger-Papić S; Finderle A; Eminović S
Coll Antropol; 2010 Mar; 34(1):219-24. PubMed ID: 20432754
[TBL] [Abstract][Full Text] [Related]
14. Pre- and post-conization high-risk HPV testing predicts residual/recurrent disease in patients treated for CIN 2-3.
Alonso I; Torné A; Puig-Tintoré LM; Esteve R; Quinto L; Campo E; Pahisa J; Ordi J
Gynecol Oncol; 2006 Nov; 103(2):631-6. PubMed ID: 16780934
[TBL] [Abstract][Full Text] [Related]
15. Comparative efficacy and complication rates after local treatment for cervical intraepithelial neoplasia and stage 1a1 cervical cancer: protocol for a systematic review and network meta-analysis from the CIRCLE Group.
Athanasiou A; Veroniki AA; Efthimiou O; Kalliala I; Naci H; Bowden S; Paraskevaidi M; Martin-Hirsch P; Bennett P; Paraskevaidis E; Salanti G; Kyrgiou M
BMJ Open; 2019 Aug; 9(8):e028008. PubMed ID: 31377697
[TBL] [Abstract][Full Text] [Related]
16. Long-term risk of recurrent cervical human papillomavirus infection and precancer and cancer following excisional treatment.
Kreimer AR; Schiffman M; Herrero R; Hildesheim A; González P; Burk RD; Porras C; Sherman ME; Demuth F; Cheung L; Bratti C; Cecilia Rodríguez A
Int J Cancer; 2012 Jul; 131(1):211-8. PubMed ID: 21823117
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursors.
Arbyn M; Xu L; Simoens C; Martin-Hirsch PP
Cochrane Database Syst Rev; 2018 May; 5(5):CD009069. PubMed ID: 29740819
[TBL] [Abstract][Full Text] [Related]
18. Risk of recurrent disease following conization of cervical intraepithelial neoplasia grade 3 according to post-conization HPV status and surgical margins.
Sand FL; Frederiksen K; Kjaer SK
Gynecol Oncol; 2022 Jun; 165(3):472-477. PubMed ID: 35400526
[TBL] [Abstract][Full Text] [Related]
19. Pap Smear Combined with HPV Testing: A Reasonable Tool for Women with High-grade Cervical Intraepithelial Neoplasia Treated by LEEP.
Mo LZ; Song HL; Wang JL; He Q; Qiu ZC; Li F
Asian Pac J Cancer Prev; 2015; 16(10):4297-302. PubMed ID: 26028089
[TBL] [Abstract][Full Text] [Related]
20. Does LLETZ excision margin status predict residual disease in women who have undergone post-treatment cervical cytology and high-risk human papillomavirus testing?
Palmer JE; Ravenscroft S; Ellis K; Crossley J; Dudding N; Smith JH; Tidy JA
Cytopathology; 2016 Jun; 27(3):210-7. PubMed ID: 26415635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
